ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,030 | -70.1% | 85 | -61.4% | 0.00% | -100.0% |
| Q2 2023 | $10,149 | +31.8% | 220 | +14.6% | 0.00% | 0.0% |
| Q1 2023 | $7,699 | -62.2% | 192 | -56.4% | 0.00% | -66.7% |
| Q4 2022 | $20,385 | +307.7% | 440 | +286.0% | 0.00% | +200.0% |
| Q3 2022 | $5,000 | +150.0% | 114 | +307.1% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 28 | +16.7% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 24 | +242.9% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 7 | -58.8% | 0.00% | – |
| Q4 2019 | $1,000 | -75.0% | 17 | -80.5% | 0.00% | -100.0% |
| Q3 2019 | $4,000 | 0.0% | 87 | +38.1% | 0.00% | 0.0% |
| Q2 2019 | $4,000 | 0.0% | 63 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +100.0% | 63 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $2,000 | – | 63 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |